Observation of short-course chemotherapy plus Feitai capsule curative effect on pulmonary tuberculosis

Objective To improve the efficacy of short-course chemotherapy on pulmonary tuberculosis by taking Feitai capsule additionally.Method 110 patients with smear-positive pulmonary tuberculosis were selected and all received short-course chemotherapy,and 52 cases as the experimental group took Feitai capsule additionally for three months.The gender,age,lesion and sputum germ had no significant differences between the two groups.Results In the experimental group of 52 cases,the rate of sputum germ conversion to negative was 96.2%(50 cases) at the end of the second month,and for the control group of 58 cases,the rate was 84.48%(49 cases).It showed significant difference between the two groups(P0.05).At the end of six months,40 cases of the lesions were obviously absorbbed(76.92%),while the control group of 33 cases(56.89%).It also showed significant difference between the two groups(P0.05).In a 5-year follow-up after drug discontinuance,2 cases died accidentally and 1 case recurred(recurrence rate: 2%) in the experimental group,whereas 5 cases in the control group(recurrence rate: 8.62%) with significant group difference(P0.05).Conclusion The efficacy of short-course chemotherapy tuberculosis plus taking Feitai capsule additionally on pulmonary tuberculosis in the experimental group is better than that in the control group.